Welcome to the Precision Medicine Podcast, where experts come to discuss the problems oncologists, reference labs, and payers face as precision medicine grows, and consider solutions for advancing the quality of patient-centered cancer care.
Dr. Caroline Carney and Clynt Taylor Discuss Managing the Total Cost of Care in Precision Medicine
In this notable episode, Dr. Caroline Carney, Chief Medical Officer at Magellan Health, and Clynt Taylor, CEO at Trapelo Health, join us to discuss how collaborative technologies can help payers more effectively manage the cost of precision oncology while delivering the best outcomes for patients. Read the full summary (https://www.trapelohealth.com/magellan-trapelo-precision-medicine).
Dr. F. Anthony Greco Explains How Precision Medicine Has Led to Better Treatments for Cancers of Unknown Origins
In this episode, Dr. F. Anthony Greco, medical oncologist at Tennessee Oncology, discusses the role that precision medicine has played in improving our diagnosis and treatment of cancer.
Dr. Gabriel Bien-Willner Part 2: Helping Payers Adapt to the Paradigm Shift of Precision Medicine
In this Part 2 podcast (https://www.trapelohealth.com/precision-oncology-prior-auth) featuring Dr. Gabriel A. Bien-Willner, Medical Director of the MolDX programat Palmetto GBA, we dive into the core challenges that payers face in navigating the explosion of precision medicine tests and treatments, and specifically how the prior authorization process can be streamlined by keeping payers updated on changes in coverage policy for new genes or CDx.
Be sure to tune in to Part 1 with Dr. Bien-Willner (https://www.trapelohealth.com/reimbursement-for-genetic-testing) who speaks about reshaping reimbursement policies for genetic and genomic testing.
AbbVie’s Christopher Boone Integrates Real-World Data with Precision Medicine for Better Patient Outcomes
Christopher Boone, Vice President and Global Head of Health Economics & Outcomes Research at AbbVie, shares his thoughts on how using data to understand a patient’s real-world environment can expand the practice of Precision Medicine.
Precision Medicine is Coming Faster Than You Think: Guests Rob Metcalf and Clynt Taylor
It is fitting that our first guests on Season 3 of the Precision Medicine Podcast are Rob Metcalf, CEO of Concert Genetics and Clynt Taylor, CEO of Trapelo Health who are both innovators in precision medicine technology. What we learn from them in this episode is that after 20 years of hearing about the “promise of precision medicine,” technology has reached a critical point where it can begin to accelerate that progress. Read the full summary, listen and learn more here. (https://www.trapelohealth.com/precision-medicine-technology)
Dr. Luis Raez Discusses the Impact of Precision Medicine in Lung Cancer Treatment
In this episode (http://trapelohealth.com/lung-cancer-precision-medicine), and in honor of lung cancer awareness month we had the opportunity to speak with Dr. Luis Raez, Medical Director and Chief of Hematology Oncology at Memorial Cancer Institute who focuses on treating lung cancer. Hear how the emergence of next-generation sequencing has changed his approach to lung cancer treatment, what notable discoveries in lung cancer have occurred over the last year, and how he sees COVID-19 impacting the treatment of cancer. Tune in to the full episode here (http://trapelohealth.com/lung-cancer-precision-medicine).
Precision medicine simplified!
Superb host and a vibrant line-up of guests who aim to shed light on the advancement and practicality of precision medicine in modern medicine. Owing to the fact that there is scarce material on the topic, this podcast goes beyond educating the masses — highly informative! I discovered the show about 12 weeks ago and it has been an illuminating journey of discovery thus far. Thanks for the well organized content!